CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
Hyun Goo Kang, Tae Young Kim, Jinu Han, Sueng-Han Han
Korean J Ophthalmol. 2019;33(3):272-278.   Published online June 4, 2019
DOI: https://doi.org/10.3341/kjo.2019.0011

Excel Download

Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
Korean Journal of Ophthalmology. 2019;33(3):272   Crossref logo
Link1 Link2 Link3

Delayed Laser photocoagulation following intravitreal anti–vascular endothelial growth factor injection allows immature retinal vessels to regrow without recurrence of retinopathy of prematurity
. 2019;   Crossref logo
Link1 Link2

Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis
Canadian Journal of Ophthalmology. 2021;56(6):355-363   Crossref logo
Link1 Link2

Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti–Vascular Endothelial Growth Factor
Ophthalmology. 2021;128(8):1188-1196   Crossref logo
Link1 Link2

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity
Ophthalmology. 2015;122(5):1008-1015   Crossref logo
Link1 Link2

Short-term risk of retinal detachment following treatment of retinopathy of prematurity with laser photocoagulation versus intravitreal anti-vascular endothelial growth factor
Journal of American Association for Pediatric Ophthalmology and Strabismus. 2021;25(4):e2   Crossref logo
Link1 Link2

Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis
BMJ Open. 2021;11(2):e042384   Crossref logo
Link1

Treatment for non-type 1 retinopathy of prematurity by intravitreal injection of anti-vascular endothelial growth factor drugs
. 2022;   Crossref logo
Link1 Link2

Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes
Survey of Ophthalmology. 2021;66(4):572-584   Crossref logo
Link1 Link2

Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity
American Journal of Ophthalmology Case Reports. 2021;22:101097   Crossref logo
Link1 Link2